# A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

> **NCT03218501** · PHASE2 · COMPLETED · sponsor: **Sanwa Kagaku Kenkyusho Co., Ltd.** · enrollment: 269 (actual)

## Conditions studied

- Uremic Pruritus in Hemodialysis Patients

## Interventions

- **DRUG:** SK-1405 high dose
- **DRUG:** SK-1405 low dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03218501
- **Lead sponsor:** Sanwa Kagaku Kenkyusho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-28
- **Primary completion:** 2018-05-25
- **Final completion:** 2018-05-25
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218501, "A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03218501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*